Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular Neurology Fellowship: Where Do We Go From Here?

Stroke·2026
Same author

Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.

Lancet (London, England)·2026
Same author

Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study.

Stroke·2026
Same author

The Fast and the Fragile: Neurosurgical Trauma in the Age of Micromobility.

Neurosurgery·2026
Same author

CREST-2: Providing Clarity on Managing Asymptomatic Carotid Stenosis.

Stroke (Hoboken, N.J.)·2026
Same author

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Related Experiment Video

Updated: May 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Selecting stroke patients for intra-arterial therapy.

Clotilde Balucani1, James C Grotta

  • 1Department of Neurology, SUNY Downstate Medical Center, Brooklyn, NY, USA.

Neurology
|March 7, 2012
PubMed
Summary

New treatments for acute ischemic stroke are needed. Optimizing intra-arterial therapy (IAT) patient selection using clinical factors and time may improve outcomes and resource use.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Emergency Medicine

Background:

  • Acute ischemic stroke requires improved treatments for arterial recanalization and patient outcomes.
  • Intra-arterial therapy (IAT) shows promise but doesn't always translate to better results.
  • Efficient patient selection and reperfusion strategies are crucial for optimizing IAT.

Purpose of the Study:

  • To explore methods for improving patient selection for intra-arterial therapy (IAT).
  • To identify predictors for better clinical outcomes in acute ischemic stroke patients undergoing IAT.
  • To evaluate the role of clinical factors and time in optimizing IAT efficacy.

Main Methods:

  • Review of existing clinical data and approaches for acute ischemic stroke treatment.

More Related Videos

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
09:00

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke

Published on: February 10, 2023

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Related Experiment Videos

Last Updated: May 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
09:00

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke

Published on: February 10, 2023

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

  • Analysis of factors influencing recanalization and patient outcomes in IAT.
  • Comparison of high-tech imaging versus low-tech clinical assessments for patient selection.

    • Main Results:

    • Increased recanalization rates with IAT do not consistently improve patient outcomes.
    • Clinical factors (age, glucose, stroke severity, infarct on CT) and time are critical.
    • Low-tech approaches may efficiently optimize patient selection for IAT.

    Conclusions:

    • Optimizing patient selection is key to improving outcomes with intra-arterial therapy.
    • Clinical factors and time are valuable, potentially efficient predictors for IAT.
    • A combination of predictors will likely identify ideal candidates for IAT and future therapies.